Walvax Biotechnology Co., Ltd. (SHE:300142)

Walvax Biotechnology Revenue

Walvax Biotechnology had revenue of 390.37M CNY in the quarter ending June 30, 2026, a decrease of -43.58%. This brings the company's total for the last twelve months to 2.10B, down -17.47% year-over-year. In the year 2025, Walvax Biotechnology had annual revenue of 2.42B, down -14.29%. That makes Walvax Biotechnology the 14,193rd largest company in the world by revenue and 2,532nd in China.

• Revenue (ttm): 2.10B
• Revenue Growth: -17.47%
• P/S Ratio: 9.19
• Revenue / Employee: 1.06M
• Employees: 1,981
• Market Cap: 19.46B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Eastern China 679.27M 28.1%
• Overseas Region 522.04M 21.6%
• South China Region 400.71M 16.6%
• Southwest Northwest Region 346.88M 14.3%
• Central China Region 256.31M 10.6%
• Northeast and North China 213.01M 8.8%

Fiscal year ended Dec 31, 2025 See the full Walvax Biotechnology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.42B	-403.21M	-14.29%
Dec 31, 2024	2.82B	-1.29B	-31.41%
Dec 31, 2023	4.11B	-972.67M	-19.12%
Jan 1, 2023	5.09B	1.62B	46.89%
Jan 1, 2022	3.46B	523.81M	17.82%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error